Ignite Creation Date:
2025-12-24 @ 11:14 PM
Ignite Modification Date:
2026-05-19 @ 12:50 PM
Study NCT ID:
NCT01777256
Status:
TERMINATED
Last Update Posted:
2017-04-26
First Post:
2013-01-24
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
An Adaptive Phase II Study to Evaluate the Efficacy, Pharmacodynamics, Safety and Tolerability of GSK2586184
Sponsor:
GlaxoSmithKline
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Systemic Lupus Erythematosus | View |